A Comprehensive Guide to Follow-up and Support in IVF and Artificial Fertilisation

The journey through assisted reproductive technology is often viewed as a series of high-stakes milestones: the initial consultation, the stimulation phase, and the critical moment of the procedure itself. However, fertility specialists emphasize that the treatment cycle does not end when the embryo transfer or insemination is complete. The period immediately following the procedure—often referred to as the luteal phase—is a medically critical window that requires vigilant monitoring, precise pharmacological support, and robust emotional care.

For patients undergoing treatment at leading medical centers like Liv Hospital, the post-procedural phase is structured with the same rigor as the intervention itself. Understanding the physiological and psychological demands of this period is essential for optimizing outcomes and maintaining maternal well-being.

Immediate Post-Procedural Care and Monitoring

Whether a patient undergoes In Vitro Fertilization (IVF) or another form of artificial fertilisation such as Intrauterine Insemination (IUI), the immediate priority is physiological recovery. While these procedures are generally minimally invasive, the body has undergone significant hormonal manipulation.

In the first 24 to 48 hours, patients are typically advised to rest and limit strenuous physical activity. This precaution helps to minimize uterine contractions, which, while natural, are ideally kept to a minimum to facilitate implantation. Medical teams provide specific instructions regarding “pelvic rest,” which often includes abstaining from sexual intercourse and high-impact exercise during the implantation window.

A primary focus during this early stage is monitoring for Ovarian Hyperstimulation Syndrome (OHSS). This condition can occur as a response to the injectable hormones used to stimulate egg production. Symptoms such as severe abdominal bloating, rapid weight gain (more than 1 kg in 24 hours), nausea, or shortness of breath require immediate medical attention. While mild cases are common and manageable with hydration and rest, the follow-up protocol ensures that any progression to moderate or severe OHSS is identified and treated instantly to prevent complications.

The Pillar of Success: Luteal Phase Support

The cornerstone of the IVF Artificial Fertilisation Follow-up and Support protocol is hormonal supplementation. In a natural menstrual cycle, the corpus luteum (the structure formed from the follicle after ovulation) produces progesterone, a hormone vital for thickening the uterine lining (endometrium) and maintaining a pregnancy.

In assisted reproductive cycles, the natural production of progesterone may be insufficient. The medications used to suppress the ovaries to prevent premature ovulation can inadvertently suppress the corpus luteum’s function. Furthermore, during egg retrieval in IVF, granulosa cells that support progesterone production are removed along with the eggs.

To counteract this “luteal phase defect,” fertility specialists prescribe exogenous progesterone. This supplementation typically begins on the day of or the day after the procedure and is administered via vaginal suppositories, intramuscular injections, or oral capsules. In some protocols, estrogen supplementation is also added to further stabilize the endometrial lining. Adherence to this medication schedule is non-negotiable; missing doses can lead to a drop in hormone levels that might destabilize the uterine environment, potentially compromising the implantation of the embryo.

Navigating the “Two-Week Wait”

The interval between the procedure and the pregnancy test—commonly known as the “two-week wait”—is physiologically active but psychologically taxing. During this time, the embryo (or fertilized egg) must attach to the uterine wall and begin the complex process of implantation.

Medical advice during this period focuses on maintaining a “normal” routine while avoiding extremes. Patients are encouraged to eat a balanced diet rich in antioxidants and to stay hydrated. However, there is a strong medical consensus against the use of home pregnancy tests during this window. The “trigger shot” (hCG injection) used to mature the eggs prior to the procedure can remain in the bloodstream for up to 10 days. Testing too early can result in a false positive (detecting the trigger shot rather than a pregnancy) or a false negative (testing before endogenous hCG levels are detectable), both of which can cause unnecessary emotional distress.

Diagnostic Confirmation and Future Planning

The definitive step in the follow-up process is the quantitative Beta-hCG blood test. Unlike urine tests, this blood analysis measures the exact concentration of human chorionic gonadotropin.

• Positive Outcome: If the test confirms pregnancy, the patient is not immediately discharged to standard obstetric care. Instead, they remain under the care of the fertility clinic for “early pregnancy monitoring.” This typically involves repeat blood tests every 48 hours to ensure hormone levels are rising appropriately, followed by an early ultrasound around the 6th or 7th week to confirm a fetal heartbeat and rule out ectopic pregnancy.
• Negative Outcome: If the cycle is unsuccessful, the follow-up consultation becomes a critical diagnostic tool. The medical team reviews the cycle’s data—ovarian response, fertilization rates, and embryo quality—to adjust the protocol for future attempts.